Association of Disease Activity with Serum and Tear IL-2 Levels in Behc, et Disease
| dc.contributor.author | Turkcuoglu, Peykan | |
| dc.contributor.author | Arat, Yonca Ozkan | |
| dc.contributor.author | Kan, Emrah | |
| dc.contributor.author | Kan, Elif Kilic | |
| dc.contributor.author | Chaudhry, Imtiaz A. | |
| dc.contributor.author | Koca, Suleyman | |
| dc.contributor.author | Ilhan, Nevin | |
| dc.date.accessioned | 2026-08-12T17:32:35Z | |
| dc.date.issued | 2016 | |
| dc.department | Fırat Üniversitesi | |
| dc.description.abstract | Purpose: To investigate the association of Behcet disease activity with serum and tear interleukin-2 levels. Methods: The study was designed as a prospective case control study. The study population consisted of 45 patients with Behcet disease and 24 age and sex-matched healthy participants. Behcet disease patients were classified as active (24 patients) or inactive (21 patients) according to disease activity. Serum and tear interleukin-2 levels were determined using the enzyme-linked immunosorbent assay method. Results: The mean serum and tear interleukin-2 levels of the active disease, inactive disease, and control groups were 17.04 +/- 5.02 and 32.61 +/- 16.53 pg/mL; 15.20 +/- 4.68 and 29.61 +/- 8.30 pg/mL; and 14.22 +/- 4.18 and 28.89 +/- 8.73 pg/mL, respectively. There was no statistically significant difference between the groups with respect to all measured data. Conclusions: There was no significant difference in serum or tear IL-2 levels between Behcet patients and controls; there was no association of disease activity with serum and tear IL-2 levels. | |
| dc.identifier.doi | 10.3109/09273948.2014.1003661 | |
| dc.identifier.endpage | 318 | |
| dc.identifier.issn | 0927-3948 | |
| dc.identifier.issn | 1744-5078 | |
| dc.identifier.issue | 3 | |
| dc.identifier.orcid | 0000-0003-4995-430X | |
| dc.identifier.orcid | 0000-0002-9750-6213 | |
| dc.identifier.orcid | 0000-0002-6578-7444 | |
| dc.identifier.orcid | 0000-0002-0208-8929 | |
| dc.identifier.orcid | 0000-0001-5056-4689 | |
| dc.identifier.pmid | 26110544 | |
| dc.identifier.scopus | 2-s2.0-84939525492 | |
| dc.identifier.scopusquality | Q1 | |
| dc.identifier.startpage | 313 | |
| dc.identifier.uri | https://doi.org/10.3109/09273948.2014.1003661 | |
| dc.identifier.uri | https://hdl.handle.net/11508/56699 | |
| dc.identifier.volume | 24 | |
| dc.identifier.wos | WOS:000377981500012 | |
| dc.identifier.wosquality | Q2 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | PubMed | |
| dc.language.iso | en | |
| dc.publisher | Taylor & Francis Inc | |
| dc.relation.ispartof | Ocular Immunology and Inflammation | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.snmz | KA_WoS_20260511 | |
| dc.subject | Behcet | |
| dc.subject | Behcet's disease | |
| dc.subject | interleukin | |
| dc.subject | interleukin-2 | |
| dc.subject | tear interleukin | |
| dc.title | Association of Disease Activity with Serum and Tear IL-2 Levels in Behc, et Disease | |
| dc.type | Article |







